The data illustrates Biogen's top products from 2015 to 2017, based on revenue. Biogen Inc. is a Massachusetts-based biotech company specializing in drugs for neurological disorders, autoimmune disorders and cancer. In 2017, the company's top product Tecfidera generated revenues of around 4.2 billion USD.
Tecfidera | 3638.4 | 3968.1 | 4214 |
Interferon (incl. Avonex and Plegridy) | 2968.7 | 2795.2 | 2645.8 |
Tysabri | 1886.1 | 1963.8 | 1973.1 |
Spinraza | 4.6 | 883.7 | |
Benepali | 100.6 | 370.8 | |
Fampyra | 89.7 | 84.9 | 91.6 |
Zinbryta | 7.8 | 52.7 | |
Eloctate | 319.7 | 513.2 | 48.4 |
Fumaderm | 51.4 | 45.9 | 39.6 |
Alprolix | 234.5 | 333.7 | 26 |